Lina Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Linagliptin

Indications/Uses

Adjunct to diet & exercise to improve glycemic control in adults w/ type 2 DM.

Click to view Lina detailed prescribing information

Dosage/Direction for Use

5 mg once daily.

Click to view Lina detailed prescribing information

Overdosage

View Lina overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Should not be used in patients w/ type 1 DM or for diabetic ketoacidosis treatment.

Click to view Lina detailed prescribing information

Special Precautions

Promptly discontinue if pancreatitis is suspected. Higher rate of hypoglycemia in combination w/ insulin in patients w/ severe renal impairment. Pregnancy & lactation.

Click to view Lina detailed prescribing information

Use In Pregnancy & Lactation

Click to view Lina detailed prescribing information

Adverse Reactions

Hypoglycemia, hyperlipidemia, hypertriglyceridemia, wt gain; urticaria, angioedema, localized skin exfoliation & bronchial hyperreactivity; nasopharyngitis, cough, upper resp infection (in combination w/ glimepiride); arthralgia, back pain, myalgia, pain in extremities; pancreatitis; headache; diarrhea, constipation; UTI (in combination w/ specific antidiabetics); increased uric acid.

Drug Interactions

Decreased efficacy w/ rifampicin; efficacy may be decreased by strong P-gp or CYP3A4 inducer.

Click to view Lina detailed prescribing information

Storage

View Lina storage conditions for details to ensure optimal shelf-life.

Description

View Lina description for details of the chemical structure and excipients (inactive components).

Action

View Lina mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BH05 - linagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Lina FC tab 5 mg

Packing/Price

3 × 10's

Lina

linagliptin

Manufacturer:

CCL Pharma

Distributor:

Manawhari